Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Jan 4:9:18.
doi: 10.3389/fnsyn.2017.00018. eCollection 2017.

Commentary: Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease

Affiliations
Comment

Commentary: Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease

Sachchida Nand Rai et al. Front Synaptic Neurosci. .
No abstract available

Keywords: Parkinson disease; SV2C; basal ganglia; dopamine; synapses.

PubMed Disclaimer

Comment on

References

    1. Altmann V., Schumacher-Schuh A. F., Rieck M., Callegari-Jacques S. M., Rieder C. R., Hutz M. H. (2016). Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson's disease. Pharmacogenomics 17, 481–488. 10.2217/pgs.15.183 - DOI - PubMed
    1. Bisaglia M., Greggio E., Beltramini M., Bubacco L. (2013). Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies. FASEB. J. 27, 2101–2110. 10.1096/fj.12-226852 - DOI - PubMed
    1. Dardou D., Dassesse D., Cuvelier L., Deprez T., De Ryck M., Schiffmann S. N. (2011). Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system. Brain Res. 1367, 130–145. 10.1016/j.brainres.2010.09.063 - DOI - PubMed
    1. Dunn A. R., Stout K. A., Ozawa M., Lohr K. M., Hoffman C. A., Bernstein A. I., et al. . (2017). Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 114, E2253–E2262. 10.1073/pnas.1616892114 - DOI - PMC - PubMed
    1. Hernán M. A., Takkouche B., Caamaño-Isorna F., Gestal-Otero J. J. (2002). A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann. Neurol. 52, 276–284. 10.1002/ana.10277 - DOI - PubMed

LinkOut - more resources